FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065447632> ?p ?o ?g. }

• W2065447632 endingPage "496" @default.
• W2065447632 startingPage "487" @default.
• W2065447632 abstract "Fibroblast activation protein-α (FAPα) is a tumor-associated antigen uniquely expressed by reactive stromal fibroblasts in the majority of human epithelial tumors. FAPα also possesses both post-prolyl peptidase and endopeptidase activities. Consequently, FAPα is increasingly considered as a potential pan-tumor target for designing tumor-targeted prodrugs. We previously conjugated Doxorubicin (Dox) with a FAPα-specific dipeptide (Z-Gly-Pro) to develop a FAPα-targeting prodrug of Dox (FTPD). The aim of current work was to validate the tumor targeting of this targeted-delivery strategy. The results demonstrated that FTPD could effectually release Dox upon the hydrolysis of FAPα as well as the incubation with tumor homogenate of FAPα-positive tumor (4T1 tumor), while it was highly stable in mouse plasma and a variety of tissue homogenates including heart, liver, and so on. And the FAPα-cleaved FTPD exhibited significantly higher cytotoxicity against 4T1 cells in vitro than the uncatalyzed prodrug. Additionally, FTPD produced similar antitumor efficacy in 4T1 tumor-bearing mice to free Dox without obvious cardiotoxic effect. Moreover, subsequent study indicated that the accumulation of FTPD reduced significantly in the heart compared to free Dox. These findings suggest that such FAPα-based prodrug strategy is promising to achieve targeted delivery of antitumor agents." @default.
• W2065447632 created "2016-06-24" @default.
• W2065447632 creator A5024120345 @default.
• W2065447632 creator A5028448066 @default.
• W2065447632 creator A5042206049 @default.
• W2065447632 creator A5048536185 @default.
• W2065447632 creator A5058814917 @default.
• W2065447632 creator A5080788421 @default.
• W2065447632 creator A5090797260 @default.
• W2065447632 date "2011-02-02" @default.
• W2065447632 modified "2023-09-27" @default.
• W2065447632 title "Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug" @default.
• W2065447632 cites W1518396628 @default.
• W2065447632 cites W1602745268 @default.
• W2065447632 cites W1964818072 @default.
• W2065447632 cites W1968893400 @default.
• W2065447632 cites W1975016799 @default.
• W2065447632 cites W1980615123 @default.
• W2065447632 cites W1983820109 @default.
• W2065447632 cites W1994935137 @default.
• W2065447632 cites W1995358920 @default.
• W2065447632 cites W2002145465 @default.
• W2065447632 cites W2013867374 @default.
• W2065447632 cites W2023070110 @default.
• W2065447632 cites W2037099316 @default.
• W2065447632 cites W2040396297 @default.
• W2065447632 cites W2046981993 @default.
• W2065447632 cites W2047764904 @default.
• W2065447632 cites W2067488225 @default.
• W2065447632 cites W2072331569 @default.
• W2065447632 cites W2074861906 @default.
• W2065447632 cites W2078502914 @default.
• W2065447632 cites W2087709256 @default.
• W2065447632 cites W2101545809 @default.
• W2065447632 cites W2102897174 @default.
• W2065447632 cites W2121354326 @default.
• W2065447632 cites W2142401479 @default.
• W2065447632 cites W2155635155 @default.
• W2065447632 cites W2165594693 @default.
• W2065447632 cites W4237195954 @default.
• W2065447632 cites W4242666483 @default.
• W2065447632 cites W4377248292 @default.
• W2065447632 doi "https://doi.org/10.3109/1061186x.2010.511225" @default.
• W2065447632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21284542" @default.
• W2065447632 hasPublicationYear "2011" @default.
• W2065447632 type Work @default.
• W2065447632 sameAs 2065447632 @default.
• W2065447632 citedByCount "53" @default.
• W2065447632 countsByYear W20654476322012 @default.
• W2065447632 countsByYear W20654476322013 @default.
• W2065447632 countsByYear W20654476322014 @default.
• W2065447632 countsByYear W20654476322015 @default.
• W2065447632 countsByYear W20654476322016 @default.
• W2065447632 countsByYear W20654476322017 @default.
• W2065447632 countsByYear W20654476322018 @default.
• W2065447632 countsByYear W20654476322019 @default.
• W2065447632 countsByYear W20654476322020 @default.
• W2065447632 countsByYear W20654476322021 @default.
• W2065447632 countsByYear W20654476322022 @default.
• W2065447632 countsByYear W20654476322023 @default.
• W2065447632 crossrefType "journal-article" @default.
• W2065447632 hasAuthorship W2065447632A5024120345 @default.
• W2065447632 hasAuthorship W2065447632A5028448066 @default.
• W2065447632 hasAuthorship W2065447632A5042206049 @default.
• W2065447632 hasAuthorship W2065447632A5048536185 @default.
• W2065447632 hasAuthorship W2065447632A5058814917 @default.
• W2065447632 hasAuthorship W2065447632A5080788421 @default.
• W2065447632 hasAuthorship W2065447632A5090797260 @default.
• W2065447632 hasConcept C108215921 @default.
• W2065447632 hasConcept C109316439 @default.
• W2065447632 hasConcept C111798993 @default.
• W2065447632 hasConcept C121608353 @default.
• W2065447632 hasConcept C126322002 @default.
• W2065447632 hasConcept C126511603 @default.
• W2065447632 hasConcept C178790620 @default.
• W2065447632 hasConcept C185592680 @default.
• W2065447632 hasConcept C202751555 @default.
• W2065447632 hasConcept C2776694085 @default.
• W2065447632 hasConcept C2779820397 @default.
• W2065447632 hasConcept C2780035454 @default.
• W2065447632 hasConcept C2781303535 @default.
• W2065447632 hasConcept C502942594 @default.
• W2065447632 hasConcept C55493867 @default.
• W2065447632 hasConcept C71924100 @default.
• W2065447632 hasConcept C98274493 @default.
• W2065447632 hasConceptScore W2065447632C108215921 @default.
• W2065447632 hasConceptScore W2065447632C109316439 @default.
• W2065447632 hasConceptScore W2065447632C111798993 @default.
• W2065447632 hasConceptScore W2065447632C121608353 @default.
• W2065447632 hasConceptScore W2065447632C126322002 @default.
• W2065447632 hasConceptScore W2065447632C126511603 @default.
• W2065447632 hasConceptScore W2065447632C178790620 @default.
• W2065447632 hasConceptScore W2065447632C185592680 @default.
• W2065447632 hasConceptScore W2065447632C202751555 @default.
• W2065447632 hasConceptScore W2065447632C2776694085 @default.
• W2065447632 hasConceptScore W2065447632C2779820397 @default.
• W2065447632 hasConceptScore W2065447632C2780035454 @default.
• W2065447632 hasConceptScore W2065447632C2781303535 @default.

• next